Pregnancy and delivery in women treated with renal replacement therapy: A literature review
Abstract
Abstract. The problem of pregnancy and delivery in women with end-stage kidney disease is becoming increasingly important, and the number of such women who are pregnant, receiving kidney replacement therapy, is growing every year. Improvements in dialysis therapy have led to improved obstetric and perinatal outcomes, but the risk of various obstetric and perinatal complications remains extremely high. In this review, we analyzed recently published data on management and outcomes of pregnancy in women with end-stage kidney disease receiving dialysis.
Downloads
References
Kolesnyk MO, hol. redaktor. Natsionalnyi reiestr khvorykh na khronichnu khvorobu nyrok ta patsi-ientiv z hostrym poshkodzhenniam nyrok: 2019 rik / uklad. NI Kozliuk, OО Razvazhaieva; Derzhavna ustanova «Instytut nefrolohii NAMN Ukrainy». Kyiv; 2020:179 s. [In Ukrainian].
Asamiya Y, Otsubo S, Matsuba Y, et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int. 2009:75(11):1217–1222. doi: 10.1038/ki.2009.48.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.















